Skip to main content
NCBI home page
Thorax logoLink to Thorax
editorial
. 1994 Jun;49(6):537–539. doi: 10.1136/thx.49.6.537

Tuberculosis and HIV: light after darkness.

J M Grange, J L Stanford, G Rook, P Onyebujoh, P A Bretscher
PMCID: PMC474938  PMID: 8016788

Full text

PDF
537

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrahams E. W. 'Original mycobacterial sin'. Tubercle. 1970 Sep;51(3):316–321. doi: 10.1016/0041-3879(70)90026-7. [DOI] [PubMed] [Google Scholar]
  2. Bloom B. R., Salgame P., Diamond B. Revisiting and revising suppressor T cells. Immunol Today. 1992 Apr;13(4):131–136. doi: 10.1016/0167-5699(92)90110-S. [DOI] [PubMed] [Google Scholar]
  3. Bothamley G. H., Grange J. M. The Koch phenomenon and delayed hypersensitivity: 1891-1991. Tubercle. 1991 Mar;72(1):7–11. doi: 10.1016/0041-3879(91)90018-n. [DOI] [PubMed] [Google Scholar]
  4. Bretscher P. A. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy. Immunol Today. 1992 Sep;13(9):342–345. doi: 10.1016/0167-5699(92)90168-7. [DOI] [PubMed] [Google Scholar]
  5. Bretscher P. A., Wei G., Menon J. N., Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science. 1992 Jul 24;257(5069):539–542. doi: 10.1126/science.1636090. [DOI] [PubMed] [Google Scholar]
  6. Brown J. A., Stone M. M. B.C.G. vaccination of children against leprosy: first results of a trial in Uganda. Br Med J. 1966 Jan 1;1(5478):7–14. doi: 10.1136/bmj.1.5478.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Clerici M., Berzofsky J. A., Shearer G. M., Tacket C. O. Exposure to human immunodeficiency virus (HIV) type I indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies [corrected]. J Infect Dis. 1991 Jul;164(1):178–182. doi: 10.1093/infdis/164.1.178. [DOI] [PubMed] [Google Scholar]
  8. Clerici M., Shearer G. M. A TH1-->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993 Mar;14(3):107–111. doi: 10.1016/0167-5699(93)90208-3. [DOI] [PubMed] [Google Scholar]
  9. Davies P. D. Tuberculosis and HIV: blind man's buff. Thorax. 1993 Mar;48(3):193–194. doi: 10.1136/thx.48.3.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fine P. E. The BCG story: lessons from the past and implications for the future. Rev Infect Dis. 1989 Mar-Apr;11 (Suppl 2):S353–S359. doi: 10.1093/clinids/11.supplement_2.s353. [DOI] [PubMed] [Google Scholar]
  11. Flynn J. L., Goldstein M. M., Triebold K. J., Koller B., Bloom B. R. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12013–12017. doi: 10.1073/pnas.89.24.12013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grzych J. M., Pearce E., Cheever A., Caulada Z. A., Caspar P., Heiny S., Lewis F., Sher A. Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J Immunol. 1991 Feb 15;146(4):1322–1327. [PubMed] [Google Scholar]
  13. Kardjito T., Beck J. S., Grange J. M., Stanford J. L. A comparison of the responsiveness to four new tuberculins among Indonesian patients with pulmonary tuberculosis and healthy subjects. Eur J Respir Dis. 1986 Sep;69(3):142–145. [PubMed] [Google Scholar]
  14. LeClercq S. A., Bretscher P. A. T cells expressing delayed-type hypersensitivity can be derived from a humorally immune lymphocyte population. Eur J Immunol. 1987 Jul;17(7):949–954. doi: 10.1002/eji.1830170709. [DOI] [PubMed] [Google Scholar]
  15. Lefford M. J. Editorial: Delayed hypersensitivity and immunity in tuberculosis. Am Rev Respir Dis. 1975 Mar;111(3):243–246. doi: 10.1164/arrd.1975.111.3.243. [DOI] [PubMed] [Google Scholar]
  16. Mosmann T. R. Regulation of immune responses by T cells with different cytokine secretion phenotypes: role of a new cytokine, cytokine synthesis inhibitory factor (IL10). Int Arch Allergy Appl Immunol. 1991;94(1-4):110–115. doi: 10.1159/000235340. [DOI] [PubMed] [Google Scholar]
  17. Nye P. M., Stanford J. L., Rook G. A., Lawton P., MacGregor M., Reily C., Humber D., Orege P., Revankar C. R., Terencio de las Aguas J. Suppressor determinants of mycobacteria and their potential relevance to leprosy. Lepr Rev. 1986 Jun;57(2):147–157. doi: 10.5935/0305-7518.19860018. [DOI] [PubMed] [Google Scholar]
  18. Paul R. C., Stanford J. L., Carswell J. W. Multiple skin testing in leprosy. J Hyg (Lond) 1975 Aug;75(1):57–68. doi: 10.1017/s0022172400047069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rook G. A., Onyebujoh P., Stanford J. L. TH1/TH2 switching and loss of CD4+ T cells in chronic infections: an immunoendocrinological hypothesis not exclusive to HIV. Immunol Today. 1993 Nov;14(11):568–569. doi: 10.1016/0167-5699(93)90190-V. [DOI] [PubMed] [Google Scholar]
  20. Rook G. A., Onyebujoh P., Wilkins E., Ly H. M., al Attiyah R., Bahr G., Corrah T., Hernandez H., Stanford J. L. A longitudinal study of per cent agalactosyl IgG in tuberculosis patients receiving chemotherapy, with or without immunotherapy. Immunology. 1994 Jan;81(1):149–154. [PMC free article] [PubMed] [Google Scholar]
  21. Rook G. A., Onyebujoh P., Wilkins E., Ly H. M., al Attiyah R., Bahr G., Corrah T., Hernandez H., Stanford J. L. A longitudinal study of per cent agalactosyl IgG in tuberculosis patients receiving chemotherapy, with or without immunotherapy. Immunology. 1994 Jan;81(1):149–154. [PMC free article] [PubMed] [Google Scholar]
  22. Salk J., Bretscher P. A., Salk P. L., Clerici M., Shearer G. M. A strategy for prophylactic vaccination against HIV. Science. 1993 May 28;260(5112):1270–1272. doi: 10.1126/science.8098553. [DOI] [PubMed] [Google Scholar]
  23. Sher A., Gazzinelli R. T., Oswald I. P., Clerici M., Kullberg M., Pearce E. J., Berzofsky J. A., Mosmann T. R., James S. L., Morse H. C., 3rd Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev. 1992 Jun;127:183–204. doi: 10.1111/j.1600-065x.1992.tb01414.x. [DOI] [PubMed] [Google Scholar]
  24. Stanford J. L., Grange J. M. New concepts for the control of tuberculosis in the twenty first century. J R Coll Physicians Lond. 1993 Jul;27(3):218–223. [PMC free article] [PubMed] [Google Scholar]
  25. Stanford J. L. Koch's phenomenon: can it be corrected? Tubercle. 1991 Dec;72(4):241–249. doi: 10.1016/0041-3879(91)90047-v. [DOI] [PubMed] [Google Scholar]
  26. Stanford J. L., Nye P. M., Rook G. A., Samuel N., Fairbank A. A preliminary investigation of the responsiveness or otherwise of patients and staff of a leprosy hospital to groups of shared or species antigens of mycobacteria. Lepr Rev. 1981 Dec;52(4):321–327. doi: 10.5935/0305-7518.19810043. [DOI] [PubMed] [Google Scholar]
  27. Stanford J. L., Onyebujoh P. C., Rook G. A., Grange J. M., Pozniak A. Old plague, new plague, and a treatment for both? AIDS. 1993 Sep;7(9):1275–1277. [PubMed] [Google Scholar]
  28. Stanford J. L., Paul R. C. A preliminary study of the effect of contact with environmental mycobacteria on the pattern of sensitivity to a range of new tuberculins amongst Ugandan adults. J Hyg (Lond) 1976 Apr;76(2):205–214. doi: 10.1017/s0022172400055108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stanford J. L., Rook G. A., Samuel N., Madlener F., Khamenei A. A., Nemati T., Modabber F., Rees R. J. Preliminary immunological studies in search of correlates of protective immunity carried out on some Iranian leprosy patients and their families. Lepr Rev. 1980 Dec;51(4):303–314. doi: 10.5935/0305-7518.19800031. [DOI] [PubMed] [Google Scholar]
  30. Stanford J. L., Shield M. J., Rook G. A. How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle. 1981 Mar;62(1):55–62. doi: 10.1016/0041-3879(81)90037-4. [DOI] [PubMed] [Google Scholar]
  31. Surcel H. M., Troye-Blomberg M., Paulie S., Andersson G., Moreno C., Pasvol G., Ivanyi J. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology. 1994 Feb;81(2):171–176. [PMC free article] [PubMed] [Google Scholar]
  32. Yong A. J., Grange J. M., Tee R. D., Beck J. S., Bothamley G. H., Kemeny D. M., Kardjito T. Total and anti-mycobacterial IgE levels in serum from patients with tuberculosis and leprosy. Tubercle. 1989 Dec;70(4):273–279. doi: 10.1016/0041-3879(89)90021-4. [DOI] [PubMed] [Google Scholar]
  33. Youmans G. P. Relation between delayed hypersensitivity and immunity in tuberculosis. Am Rev Respir Dis. 1975 Feb;111(2):109–118. doi: 10.1164/arrd.1975.111.2.109. [DOI] [PubMed] [Google Scholar]
  34. Young D. B., Garbe T. R. Heat shock proteins and antigens of Mycobacterium tuberculosis. Infect Immun. 1991 Sep;59(9):3086–3093. doi: 10.1128/iai.59.9.3086-3093.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES